Log in
Enquire now
‌

US Patent 10493148 PD-1 agonist antibodies and uses thereof

Patent 10493148 was granted and assigned to Eli Lilly and Company on December, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Eli Lilly
Eli Lilly
Current Assignee
Eli Lilly
Eli Lilly
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10493148
Date of Patent
December 3, 2019
Patent Application Number
16282609
Date Filed
February 22, 2019
Patent Citations Received
‌
US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector
0
‌
US Patent 11945852 IL-2 muteins and uses thereof
0
‌
US Patent 11965008 IL-2 muteins and uses thereof
0
‌
US Patent 11466068 Targeted immunotolerance
‌
US Patent 10961310 Targeted immunotolerance
‌
US Patent 11779632 IL-2 muteins and uses thereof
Patent Primary Examiner
‌
Nora M Rooney
Patent abstract

The present invention relates to anti-human PD-1 agonist antibodies, and uses thereof for treating autoimmune disorders such as rheumatoid arthritis or for decreasing rejection of transplanted cells and/or tissues.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10493148 PD-1 agonist antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us